AI assistant
Sending…
GENTEX CORP — Director's Dealing 2018
Mar 2, 2018
30893_dirs_2018-03-02_048eac85-e354-45a6-aca0-149b529ab041.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2018-03-01
Reporting Person: Matthews Joseph E IV (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-01 | Common Stock | M | 1060.00 | $14.70 | Acquired | 22180.00 | Direct |
| 2018-03-01 | Common Stock | S | 1060.00 | $22.5099 | Disposed | 21120.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-01 | Employee Stock Option (Right to buy) | $14.70 | M | 1060.00 | Disposed | 2023-02-22 | Common Stock (1060.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $22.50 USD to $22.515 USD; the price reported above reflects the weighted average sale price.
F2: 7-Year Grant; 20% Vesting every year for 5 years w/2 open years beginning on 22-Feb-2016
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19